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Amelioration of Normothermic Canine Liver Ischemia 
With Prostacyclin 
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J. Demetris, L. Makowka, S. Iwatsuki, and T.E. Starzl 
RECENTL Y, many agents that might pro-tect the liver from ischemic insult have 
been developed. Validation of a protective 
effect with large animal liver transplantation, 
using either dogs or pigs, is too complex and 
expensive to be used routinely. In the present 
study, a new nontransplant model of normo-
thermic liver ischemia was developed in dogs. 
The tolerance of canine liver to ischemia and 
the protective effect of prostacyclin (PGI2) 
was investigated using this system. 
MATERIALS AND METHODS 
Animal 
Beagle dogs, weighing 15-18 kg were used. They were 
intubated and placed on a ventilator after intravenous 
(IV) injection of thiopental sodium 25 mg/kg. Anesthesia 
was maintained by IV ketamine 2 mg/kg, and pancuron-
ium 0.1 mg/kg. Arterial blood pressure and central 
venous pressure were monitored throughout the opera-
tion. 
Operative Procedures 
The abdomen was entered through a midline incision. 
The liver was skeletonized, including division of all of the 
suspensory ligaments. Liver ischemia was induced by 
total occlusion of hepatic inflow with crossclamping the 
portal triad at the hilum. The splanchnic venous bed was 
decompressed by a pump-driven spleno-jugular bypass. 
The splenic vein and the external jugular vein were 
cannulated with standard No. 12-16 chest tubes (Argyle 
Division of Sherwood Medical, St Louis), which were 
connected by Tygon tubing (Norton Industrial Plastics, 
Akron, OH). A centrifugal pump (Bio Medicus, Minne-
tonka, MN) was placed in the circuit to drive the veno-
venous flow. When liver ischemia was terminated by 
releasing the clamp, the spleen and the bypass system 
were removed. Lactated Ringer's solution, 2 to 4 L, and I 
unit of blood recovered from the bypass system were 
administered to animals. No heparin was used. Cephalo-
sporin, I g, was given prior to the ischemia and continued 
for three days. The animals were fed, starting on the 
morning after operation. 
Experimental Croups 
Experimental groups and number of animals used were 
as follows: 
I. Tolerance of liver ischemia 
Group I: (N = 6) I-hour ischemia 
Group 2: (N = 6) 2-hour ischemia 
Group 3: (N = (4) 3-hour ischemia 
Group 4: (N = 7) 3.5-hour ischemia 
The experiment of three-hour ischemia, which had 
revealed an LD 50, was performed in two parts. The first 
seven experiments were by random insertion of the three-
hour experiments with other groups. Then, confirmatory 
experiments were performed later with seven more ani-
mals. 
2. Protective effect of PGI2 
Group 5: (N = 7) vehicle (glycine) 
Group 6: (N = 6) PGI2 (I ltg/kg/min) 
Group 7: (N = 6) PGI2 (2 ltg/kg/min) 
PGl2 was supplied as a crystalline powder from the 
Upjohn Company, Ltd (Kalamazoo, MI). It was dis-
solved intoa glycine buffer (pH 10.5) and administered to 
the animals through a small mesenteric vein branch for 
one hour prior to ischemia. Severe, but not lethal, hypo-
tension always occurred in animals receiving PGI2 infu-
siorr~lrdinarilyI the mean blood pressure was in the 130 
mmHg range before infusion. It decreased to the 70 
mmHg range with I ltg/kg/min of PGI2 and 50 mmHg 
with 2 ltg/kg/min of PGI2. Blood pressure returned to 
the pretreatment level immediately after PGl2 was dis-
continued. No vasopressor was administered. 
Peripheral venous blood samples were drawn serially 
for the determination of serum glutamic oxaloacetic 
transaminase (SGOT), serum glutamic pyruvic transami-
nase (SGPT), lactate dehydrogenase (LDH), total biliru-
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bin, and blood sugar until the seventh postoperative day. 
Then the animals were killed. Postmortem examination of 
these dogs and those that died before then was carried out 
immediately after death. 
Fisher's exact test and Student's t test were used for 
statistical analysis. 
RESULTS 
Tolerance of Liver Ischemia 
N one of the animals submitted to two hours 
of hepatic ischemia died within seven days, 
while one animal in group 1 submitted to one 
hour of hepa tic ischemia died 18 hours postop-
eratively from pulmonary edema with mini-
mal change in liver function and histology 
(Fig 1). With hepatic ischemia of three hours 
(group 3), half of the animals survived for 
seven days. All of the animals challenged with 
3.5 hours of ischemia (group 4) died within 48 
hours (Fig 1). Animals in group 3 and group 4 
that died had significant oozing when the 
wound was closed or had a considerable 
amount of ser.osanguinous ascites at autopsy. 
Postischemic derangements of liver func-
tion were well correlated with the duration of 
ischemia. Animals in group 3 and group 4 
developed lactic acidosis immediately after 
the ischemia, which was highest at three 
hours, as well as hypoglycemia, with the low-
est blood sugars at 12 hours. SGOT and 
SGPT were highest between 12 hours and 24 
hours and gradually decreased thereafter, 
returning to the preoperative levels by seven 
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Fig 1. Survival of dogs after different periods of 
liver ischemia. 
TODO ET AL 
days. The levels of SGOT and SGPT at 12 
hours were 416 + 489 (SD) U/L and 550 + 
844 (SD) U /L in group 1; 2,386 ± 1,829 and 
2,196 ± 2,139 in group 2; 5,340 ± 4,774 and 
7,662 ± 6,046 in group 3, and 11,749 ± 7,345 
and 11,600 ± 10,168 in group 4. The differ-
ences were highly significant between groups. 
None of the animals had elevations of biliru-
bin. 
Treatment by PGI2 
Three-hour liver ischemia was chosen to 
test the effect of PGI2 pretreatment. PGI2 
administration was associated with a dose-
dependent improvement of animal survival 
(Fig 2). All of the animals that were given 
glycine buffer vehicle died within three hours 
(group 5). In contrast, none of the animals 
died within the first 48 hours when they were 
pretreated with PGI2 (groups 6 and 7). How-
ever, three dogs (50%) of the six who received 
1 tIg/kg/min of PGl2 and one animal (15%) 
of six who received 2 tim/kg/min of PGI2 
died subsequently (Fig 2). The three animals 
that died in group 6 had serosanguinous 
ascites, and the one that died at six days in 
group 7 had increasing jaundice. 
PGI2 treatment significantly inhibited the 
elevation of transaminases (Fig 3). Hypogly-
cemia commonly observed in untreated ani-
mals was prevented well by PGI2 administra-
tion. The mean blood sugar level at 12 hours 
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Fig 2. Survival of dogs after three hours of liver 
ischemia with PGI2 pretreatment. 
PROSTACYCLIN FOR CANINE LIVER ISCHEMIA 
8,000 
7,000 
.-., 6,000 
..J 2 5,000 
.... 
o 4,000 
CO 
<fJ 
3,000 
2,000 
1,000 
013 6 12 24h 
Trealmeflt 
.-. no treatment (N:: 14) 
0-0 veh,cle (glycine) (N:: 7) 
.-. PGI?(11-'9/kg/mm) (N::6) 
0-0 PGl 2 (?!Jg/kg/min) (N::6) 
3 7d 
Postlschemic Time 
Fig 3. SGOT of dogs submitted to three hours of 
liver ischemia without (group 3) or with PGI2 pretreat-
ment. 
after ischemia was 43.9 ± 14.4 (SD) mgjdL 
in group 3, (the LD 50 controls), 78.6 ± 11.0 
in group 6 and 98.6 ± 18.9 in group 7. No 
significant elevation of serum bilirubin was 
observed in treated animals except for the one 
animal in group 7 that died at day 6. 
DISCUSSION 
The liver generally has been considered to 
be highly sensitive to ischemia. Occlusion of 
hepatic inflow for longer than 20 minutes was 
lethal in dogs, I but the risk was principally 
due to acute portal hypertension. However, 
even when the splanchnic bed was decom-
pressed with a spleno-femoral shunt2 and side-
to-side portacaval anastomosis,3 the safe limit 
was reported to be less than 60 minutes. 
In contrast, the present study using a pump-
driven spleno-jugular bypass demonstrated 
that virtually all of the dogs tolerated two 
hours of hepatic ischemia and half of them 
survived after three hours of ischemia. Liver 
damage following one hour of ischemia in this 
study was mild and transient. Hepatic injury 
became significant only when the ischemia 
time was prolonged for longer than two hours. 
These findings were consistent with those 
previously reported in pigs.4•5 It may be con-
cluded that the liver is more tolerant to 
ischemia than previously realized. Huguet has 
come to the same conclusion about the human 
liver.6 
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The model developed in this study is simple 
and highly reliable. The results in the group 3 
controls were compiled during two time peri-
ods. In the first time period, three dogs lived 
and four died. At the later time, four dogs 
lived and three dogs died. In the 14 dogs, an 
LD 50 was established. Other methods of 
inducing hepatic ischemia have been too 
extreme to permit survival of a significant 
fraction of animals/·3,7 and for that reason 
have not allowed the testing of potential thera-
peutic maneuvers or drugs. 
A protective effect of PG 12 after liver 
ischemia and preservation has already been 
claimed by others.s.1O Using PGI2 for graft 
flushing at the time of harvesting, Monden 
and Fortner8 preserved canine livers for 24 
hours and 48 hours with consistent survival. 
Attempts to confirm these observations in our 
laboratory were unsuccessful in that only one 
of eight animals survived operation, and that 
dog died after 68 hours. This disappointing 
experience led us to develop a nontransplant 
model for the evaluation of protective agents. 
Although PGI2 showed protection as reported 
herein, other prostaglandins tested to this time 
(PQEI and PGE2) have not been effective 
(unpublished data). With PGI2, our results 
suggest that pretreatment of the donor with 
PGI2 may be a useful approach rather than 
simple flushing of the hepatic graft with the 
drug as was originally reported by Monden 
and Fortner.8 
SUMMARY 
A model of hepatic ischemia was developed 
in dogs using a pump-driven splanchnic-to-
jugular vein bypass during crossclamping of 
the portal triad. An LD 50 was established 
with three hours of ischemia, PGI2 given for 
one hour before the ischemic insult amelio-
rated the ischemic injury and increased sur-
vival. 
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